A new aminoacidic derivative of valproic acid (VPA) has been synthesized and characterized by analytical and spectral data. The rationale for the preparation of such potential antiepileptic agent is based on the observation that chemical combination of the anticonvulsant pharmacophore, VPA with essential aminoacids could afford more effective and less toxic actives. The synthesis, characterization, physico-chemical parameters functional for crossing Blood Brain Barrier of N-valproyl-L-tryptophan (4) are reported. The Log D pH7.4 (0.3) indicate that (4) is adequate to cross biological membranes. Its chemical and enzymatic stability was assessed. The experiments indicate high stability of compound (4) at pH conditions of physiological fluids. Moreover, both in plasma and in cerebral enzymatic environments compound (4) doesn’t undergo cleavage after 24 h.The anticonvulsant activity of the new compound was assessed against epileptic burst discharges evoked in vitro in rat hippocampal slices (Seizure like events - SLEs) and compared with that of the widely used VPA. Compound (4), even at the lower tested concentration, when compared to VPA, showed an improved protective effect against hippocampal seizures. The collected data suggest that compound (4) could be considered a very valuable candidate for subsequent in vivo evaluation as new potential antiepileptic drug.
|Numero di pagine||9|
|Stato di pubblicazione||Published - 2011|
All Science Journal Classification (ASJC) codes
- Drug Discovery
Giannola, L. I., Lamartina, L., De Caro, V., Carletti, F., Ferraro, G., Sardo, P., Rizzo, V., Giandalia, G., Siragusa, M. G., & Friscia, S. (2011). N-valproyl-l-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug. Medicinal Chemistry, 7, 9-17.